PMID: 22658665

Ooi CY, Durie PR
Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in pancreatitis.
J Cyst Fibros. 2012 Sep;11(5):355-62. doi: 10.1016/j.jcf.2012.05.001. Epub 2012 Jun 2., [PubMed]
Sentences
No. Mutations Sentence Comment
847 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 22658665:847:382
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 22658665:847:1002
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 22658665:847:583
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 22658665:847:447
status: NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 22658665:847:280
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 22658665:847:103
status: NEW
view ABCC7 p.Arg553* details
ABCC7 p.Arg334Trp
X
ABCC7 p.Arg334Trp 22658665:847:514
status: NEW
view ABCC7 p.Arg334Trp details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 22658665:847:314
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 22658665:847:171
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Arg1162*
X
ABCC7 p.Arg1162* 22658665:847:348
status: NEW
view ABCC7 p.Arg1162* details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 22658665:847:415
status: NEW
view ABCC7 p.Gly85Glu details
Total PI Total PI+PS PIP score 621+1G>T 96 96 1.00 Classes I - III 711+1G>T 36 36 1.00 Classes I - III R553X 24 24 1.00 Classes I - III I507del 34 34 1.00 Classes I - III G542X 74 75 0.99 Classes I - III F508del 1276 1324 0.96 Classes I - III 1717-1G>A 20 21 0.95 Classes I - III W1282X 19 20 0.95 Classes I - III N1303K 45 48 0.94 Classes I - III R1162X 12 13 0.92 Classes I - III G551D 59 67 0.88 Classes I - III G85E 16 22 0.73 Classes I - III A455E 18 37 0.49 Classes IV - V 2789+5G>A 6 16 0.38 Classes IV - V R334W 1 10 0.10 Classes IV - V 3849+10kbC>T 2 22 0.09 Classes IV - V R117H 1 25 0.04 Classes IV - V Mutation Canadian Consortium for CF Genetic Studies Mutation class The PIP score for a specific mutation is the ratio between the pancreatic insufficient patients carrying the mutation (Total PI) and all pancreatic insufficient and sufficient patients (Total PI+PS) carrying the same mutation in a homozygous state or heterozygous in a combination with a severe mutation such as F508del, G551D or a Class I mutation. Login to comment
849 ABCC7 p.Arg334Trp
X
ABCC7 p.Arg334Trp 22658665:849:65
status: NEW
view ABCC7 p.Arg334Trp details
Similarly, a ratio of 0.1 demonstrates that 10% of subjects with R334W are PI. Login to comment
855 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 22658665:855:446
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 22658665:855:1270
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Pro574His
X
ABCC7 p.Pro574His 22658665:855:824
status: NEW
view ABCC7 p.Pro574His details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 22658665:855:957
status: NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 22658665:855:231
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 22658665:855:214
status: NEW
view ABCC7 p.Arg553* details
ABCC7 p.Arg334Trp
X
ABCC7 p.Arg334Trp 22658665:855:1162
status: NEW
view ABCC7 p.Arg334Trp details
ABCC7 p.Arg347Pro
X
ABCC7 p.Arg347Pro 22658665:855:987
status: NEW
view ABCC7 p.Arg347Pro details
ABCC7 p.Arg347His
X
ABCC7 p.Arg347His 22658665:855:1304
status: NEW
view ABCC7 p.Arg347His details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 22658665:855:266
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 22658665:855:114
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Arg1162*
X
ABCC7 p.Arg1162* 22658665:855:301
status: NEW
view ABCC7 p.Arg1162* details
ABCC7 p.Arg352Gln
X
ABCC7 p.Arg352Gln 22658665:855:893
status: NEW
view ABCC7 p.Arg352Gln details
ABCC7 p.Ile148Thr
X
ABCC7 p.Ile148Thr 22658665:855:376
status: NEW
view ABCC7 p.Ile148Thr details
ABCC7 p.Ile148Thr
X
ABCC7 p.Ile148Thr 22658665:855:595
status: NEW
view ABCC7 p.Ile148Thr details
ABCC7 p.Glu585*
X
ABCC7 p.Glu585* 22658665:855:908
status: NEW
view ABCC7 p.Glu585* details
ABCC7 p.Leu206Trp
X
ABCC7 p.Leu206Trp 22658665:855:1054
status: NEW
view ABCC7 p.Leu206Trp details
ABCC7 p.Gln493*
X
ABCC7 p.Gln493* 22658665:855:249
status: NEW
view ABCC7 p.Gln493* details
ABCC7 p.Val520Phe
X
ABCC7 p.Val520Phe 22658665:855:412
status: NEW
view ABCC7 p.Val520Phe details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 22658665:855:726
status: NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Ser549Asn
X
ABCC7 p.Ser549Asn 22658665:855:693
status: NEW
view ABCC7 p.Ser549Asn details
ABCC7 p.Arg560Thr
X
ABCC7 p.Arg560Thr 22658665:855:493
status: NEW
view ABCC7 p.Arg560Thr details
ABCC7 p.Pro67Leu
X
ABCC7 p.Pro67Leu 22658665:855:1234
status: NEW
view ABCC7 p.Pro67Leu details
ABCC7 p.Arg1158*
X
ABCC7 p.Arg1158* 22658665:855:524
status: NEW
view ABCC7 p.Arg1158* details
ABCC7 p.Gln1411*
X
ABCC7 p.Gln1411* 22658665:855:1105
status: NEW
view ABCC7 p.Gln1411* details
ABCC7 p.Met1101Lys
X
ABCC7 p.Met1101Lys 22658665:855:788
status: NEW
view ABCC7 p.Met1101Lys details
ABCC7 p.Arg1070Gln
X
ABCC7 p.Arg1070Gln 22658665:855:1003
status: NEW
view ABCC7 p.Arg1070Gln details
ABCC7 p.Arg1066Cys
X
ABCC7 p.Arg1066Cys 22658665:855:508
status: NEW
view ABCC7 p.Arg1066Cys details
ABCC7 p.Gln220*
X
ABCC7 p.Gln220* 22658665:855:773
status: NEW
view ABCC7 p.Gln220* details
ABCC7 p.Tyr1092*
X
ABCC7 p.Tyr1092* 22658665:855:340
status: NEW
view ABCC7 p.Tyr1092* details
ABCC7 p.Phe508Cys
X
ABCC7 p.Phe508Cys 22658665:855:1039
status: NEW
view ABCC7 p.Phe508Cys details
ABCC7 p.Arg117Cys
X
ABCC7 p.Arg117Cys 22658665:855:758
status: NEW
view ABCC7 p.Arg117Cys details
ABCC7 p.Ser489*
X
ABCC7 p.Ser489* 22658665:855:284
status: NEW
view ABCC7 p.Ser489* details
ABCC7 p.Val232Asp
X
ABCC7 p.Val232Asp 22658665:855:1432
status: NEW
view ABCC7 p.Val232Asp details
ABCC7 p.Arg75*
X
ABCC7 p.Arg75* 22658665:855:1418
status: NEW
view ABCC7 p.Arg75* details
ABCC7 p.Leu1077Pro
X
ABCC7 p.Leu1077Pro 22658665:855:477
status: NEW
view ABCC7 p.Leu1077Pro details
ABCC7 p.Gln1291His
X
ABCC7 p.Gln1291His 22658665:855:923
status: NEW
view ABCC7 p.Gln1291His details
ABCC7 p.Glu60*
X
ABCC7 p.Glu60* 22658665:855:463
status: NEW
view ABCC7 p.Glu60* details
ABCC7 p.Gly178Arg
X
ABCC7 p.Gly178Arg 22658665:855:1334
status: NEW
view ABCC7 p.Gly178Arg details
ABCC7 p.Glu116Lys
X
ABCC7 p.Glu116Lys 22658665:855:1367
status: NEW
view ABCC7 p.Glu116Lys details
ABCC7 p.Arg709*
X
ABCC7 p.Arg709* 22658665:855:1178
status: NEW
view ABCC7 p.Arg709* details
ABCC7 p.Asp579Gly
X
ABCC7 p.Asp579Gly 22658665:855:1467
status: NEW
view ABCC7 p.Asp579Gly details
ABCC7 p.Leu1335Pro
X
ABCC7 p.Leu1335Pro 22658665:855:1497
status: NEW
view ABCC7 p.Leu1335Pro details
ABCC7 p.Gln1313*
X
ABCC7 p.Gln1313* 22658665:855:742
status: NEW
view ABCC7 p.Gln1313* details
ABCC7 p.Gln814*
X
ABCC7 p.Gln814* 22658665:855:1319
status: NEW
view ABCC7 p.Gln814* details
ABCC7 p.Leu1254*
X
ABCC7 p.Leu1254* 22658665:855:877
status: NEW
view ABCC7 p.Leu1254* details
ABCC7 p.Glu193*
X
ABCC7 p.Glu193* 22658665:855:1482
status: NEW
view ABCC7 p.Glu193* details
CFTR mutation Total PI Total PI + PS PIP score CFTR mutation Total PI Total PI + PS PIP score 621+1G>T 96 96 1.00 G542X 74 75 0.99 711+1G>T 36 36 1.00 F508del 1276 1324 0.96 I507del 34 34 1.00 1717-1G>A 20 21 0.95 R553X 24 24 1.00 W1282X 19 20 0.95 Q493X 11 11 1.00 N1303K 45 48 0.94 S489X 11 11 1.00 R1162X 12 13 0.92 1154insTC 10 10 1.00 Y1092X 12 13 0.92 3659delC 9 9 1.00 I148T 10 11 0.91 CFTRdele2 7 7 1.00 V520F 9 10 0.90 4016insT 7 7 1.00 G551D 59 67 0.88 E60X 7 7 1.00 L1077P 5 6 0.83 R560T 7 7 1.00 R1066C 5 6 0.83 R1158X 7 7 1.00 2184insA 9 12 0.75 3905insT 6 6 1.00 2143delT 3 4 0.75 I148T;3199del6 5 5 1.00 1161delC 3 4 0.75 2183AA>G 5 5 1.00 3120+1G>A 3 4 0.75 1898+1G>A 5 5 1.00 S549N 3 4 0.75 2347delG 4 4 1.00 G85E 16 22 0.73 Q1313X 3 3 1.00 R117C 2 3 0.67 Q220X 3 3 1.00 M1101K 19 30 0.63 2184delA 3 3 1.00 P574H 3 5 0.60 1078delT 3 3 1.00 474del13BP 1 2 0.50 L1254X 3 3 1.00 R352Q 1 2 0.50 E585X 3 3 1.00 Q1291H 1 2 0.50 3876delA 2 2 1.00 A455E 18 37 0.49 S4X 2 2 1.00 R347P 6 15 0.40 R1070Q 2 2 1.00 2789+5G>A 6 16 0.38 F508C 2 2 1.00 L206W 6 18 0.33 DELI507 2 2 1.00 IVS8-5T 4 16 0.25 Q1411X 2 2 1.00 3272-26A>G 1 4 0.25 365-366insT 2 2 1.00 R334W 1 10 0.10 R709X 2 2 1.00 3849+10kbC>T 2 22 0.09 1138insG 2 2 1.00 P67L 1 14 0.07 CFTRdele2-4 2 2 1.00 R117H 1 25 0.04 3007delG 2 2 1.00 R347H 0 5 0.00 Q814X 2 2 1.00 G178R 0 3 0.00 394delTT 2 2 1.00 E116K 0 2 0.00 406-1G>A 2 2 1.00 875+1G>C 0 2 0.00 R75X 2 2 1.00 V232D 0 2 0.00 CFTRdel2-3 2 2 1.00 D579G 0 2 0.00 E193X 2 2 1.00 L1335P 0 2 0.00 185+1G>T 2 2 1.00 Mild mutations (based on PIP scores) are shaded in gray. Login to comment
896 ABCC7 p.Arg75Gln
X
ABCC7 p.Arg75Gln 22658665:896:66
status: NEW
view ABCC7 p.Arg75Gln details
This finding was also supported by another recent study reporting R75Q, a mild mutation, being significantly associated with chronic pancreatitis [30]. Login to comment
897 ABCC7 p.Arg75Gln
X
ABCC7 p.Arg75Gln 22658665:897:9
status: NEW
view ABCC7 p.Arg75Gln details
Although R75Q has been suggested to be a specific pancreatitis-associated mutation due to selective bicarbonate conductance defect, there have been patients not affected by pancreatitis identified with this mutation who presented with other single organ manifestations of CF in adulthood such as chronic sinopulmonary disease [31]. Login to comment